Association of artificial intelligence-powered and manual quantification of programmed death-ligand 1 (PD-L1) expression with outcomes in patients treated with nivolumab ± ipilimumab.

Association of artificial intelligence-powered and manual quantification of programmed death-ligand 1 (PD-L1) expression with outcomes in patients treated with nivolumab ± ipilimumab. Mod Pathol. 2022 11; 35(11):1529-1539.

View in: PubMed

subject areas

Antibodies, Monoclonal
Artificial Intelligence
B7-H1 Antigen
Biomarkers, Tumor
Carcinoma, Non-Small-Cell Lung
Carcinoma, Transitional Cell
Humans
Ipilimumab
Lung Neoplasms
Retrospective Studies
Urinary Bladder Neoplasms

authors with profiles

Nishant Agrawal